These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23968849)

  • 1. Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
    Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
    J Neurol Sci; 2013 Nov; 334(1-2):106-11. PubMed ID: 23968849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological rehabilitation has beneficial effects on perceived cognitive deficits in multiple sclerosis during nine-month follow-up.
    Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
    J Neurol Sci; 2013 Nov; 334(1-2):154-60. PubMed ID: 24011606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and impact of the working alliance in the neuropsychological rehabilitation of patients with multiple sclerosis.
    Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
    J Neurol Sci; 2014 Mar; 338(1-2):156-61. PubMed ID: 24433929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
    Mäntynen A; Rosti-Otajärvi E; Koivisto K; Lilja A; Huhtala H; Hämäläinen P
    Mult Scler; 2014 Jan; 20(1):99-107. PubMed ID: 23804555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.
    Amato MP; Goretti B; Viterbo RG; Portaccio E; Niccolai C; Hakiki B; Iaffaldano P; Trojano M
    Mult Scler; 2014 Jan; 20(1):91-8. PubMed ID: 23959713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis.
    Mattioli F; Stampatori C; Zanotti D; Parrinello G; Capra R
    J Neurol Sci; 2010 Jan; 288(1-2):101-5. PubMed ID: 19825502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive training in MS: effects and relation to brain atrophy.
    Hildebrandt H; Lanz M; Hahn HK; Hoffmann E; Schwarze B; Schwendemann G; Kraus JA
    Restor Neurol Neurosci; 2007; 25(1):33-43. PubMed ID: 17473394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis.
    Goretti B; Portaccio E; Ghezzi A; Lori S; Moiola L; Falautano M; Viterbo R; Patti F; Vecchio R; Pozzilli C; Bianchi V; Cappiello S; Comi G; Trojano M; Amato MP;
    Mult Scler; 2012 Mar; 18(3):329-34. PubMed ID: 21844064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specificity of attention and cognitive inhibition processes in relapsing -remitting multiple sclerosis patients with consideration of their mood level].
    Tyburski E; Potemkowski A; Cheć M; Sołtys A; Mak M; Samochowiec A
    Psychiatr Pol; 2014; 48(2):307-18. PubMed ID: 25016768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of motor imagery and relationship with depressive symptoms in mildly disabling relapsing-remitting multiple sclerosis.
    Tabrizi YM; Mazhari S; Nazari MA; Zangiabadi N; Sheibani V
    J Neurol Phys Ther; 2014 Apr; 38(2):111-8. PubMed ID: 24531344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of group cognitive rehabilitation therapy in multiple sclerosis.
    Mani A; Chohedri E; Ravanfar P; Mowla A; Nikseresht A
    Acta Neurol Scand; 2018 Jun; 137(6):589-597. PubMed ID: 29411360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis.
    Penner IK; Hubacher M; Rasenack M; Sprenger T; Weber P; Naegelin Y
    Mult Scler; 2013 Mar; 19(3):366-8. PubMed ID: 22740487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
    Gehring K; Sitskoorn MM; Gundy CM; Sikkes SA; Klein M; Postma TJ; van den Bent MJ; Beute GN; Enting RH; Kappelle AC; Boogerd W; Veninga T; Twijnstra A; Boerman DH; Taphoorn MJ; Aaronson NK
    J Clin Oncol; 2009 Aug; 27(22):3712-22. PubMed ID: 19470928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial.
    Messinis L; Nasios G; Kosmidis MH; Zampakis P; Malefaki S; Ntoskou K; Nousia A; Bakirtzis C; Grigoriadis N; Gourzis P; Papathanasopoulos P
    Behav Neurol; 2017; 2017():5919841. PubMed ID: 29463950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial.
    Schwid SR; Goodman AD; Weinstein A; McDermott MP; Johnson KP;
    J Neurol Sci; 2007 Apr; 255(1-2):57-63. PubMed ID: 17331542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
    Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A
    Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.